Cellular origin and pathophysiology of chronic lymphocytic leukemia

Marc Seifert1, Ludger Sellmann, Johannes Bloehdorn

  • 1Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Essen 45122, Germany.

Insights

Chronic lymphocytic leukemia (CLL) originates from distinct CD5+ B cell subsets. Unmutated CLL arises from mature CD5+ B cells, while mutated CLL develops from a unique CD5+CD27+ post-germinal center B cell population.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • The cellular origin of chronic lymphocytic leukemia (CLL) remains unclear, hindering a full understanding of its pathogenesis.
  • Identifying the precise cell of origin is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the cellular origins of chronic lymphocytic leukemia (CLL) by analyzing B cell subsets.
  • To identify novel protein markers associated with CLL pathogenesis.

Main Methods:

  • Transcriptome analysis of CLL and normal human B cell subsets from blood and spleen.
  • Analysis of immunoglobulin variable (IgV) gene rearrangements and B cell surface markers (CD5, CD27).
  • Proteomic analysis to identify deregulated transcription factors.

Main Results:

  • Unmutated CLL originates from unmutated mature CD5+ B cells.
  • Mutated CLL arises from a distinct CD5+CD27+ post-germinal center B cell subset.
  • Stereotyped V gene rearrangements in CD5+ B cells support their role in CLL development. Oligoclonal expansions in CD5+ B cells suggest an early phase of CLL development.
  • Novel deregulated transcription factors, including EBF1 and KLF, were identified.

Conclusions:

  • CLL originates from specific CD5+ B cell populations, with distinct subsets giving rise to unmutated and mutated forms.
  • The findings reveal a previously unrecognized B cell subset involved in mutated CLL development.
  • Identification of novel transcription factors provides new avenues for understanding CLL pathogenesis and potential therapeutic targets.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...